William B. Walkup & Associates’s AbbVie ABBV Stock Holding History

William B. Walkup & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.39M	Sell	25,392 -745	-3%	-$160K	3.08%	8
2026 Q1	$5.48M	Buy	26,137 +532	+2%	+$118K	3.27%	7
2025 Q4	$5.85M	Sell	25,605 -560	-2%	-$128K	3.2%	7
2025 Q3	$6.06M	Sell	26,165 -7	-0%	-$1.43K	3.25%	7
2025 Q2	$4.86M	Buy	26,172 +35	+0.1%	+$6.5K	2.86%	8
2025 Q1	$5.48M	Buy	26,137 +1,126	+5%	+$219K	3.34%	7
2024 Q4	$4.44M	Sell	25,011 -159	-0.6%	-$29.2K	2.81%	9
2024 Q3	$4.97M	Sell	25,170 -107	-0.4%	-$20K	3.07%	8
2024 Q2	$4.34M	Buy	+25,277	New	+$4.19M	2.84%	8

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

William B. Walkup & Associates's ABBV Position: Q2 2026 in Review

William B. Walkup & Associates reduced its AbbVie (ABBV) stake by 2.9% in Q2 2026, selling an estimated $160K and leaving 25,392 shares worth $6.39M. The position accounts for 3.08% of the portfolio, ranked #8.

William B. Walkup & Associates first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

William B. Walkup & Associates held 25,392 shares of AbbVie worth $6.39M as of Q2 2026.
William B. Walkup & Associates sold 745 AbbVie shares in Q2 2026, an estimated $160K.
AbbVie made up 3.08% of William B. Walkup & Associates's portfolio in Q2 2026, its #8 holding.
William B. Walkup & Associates first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on William B. Walkup & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.